Chlorhexidine Drying Time

Drying Time Clinical Trial

— Chlorhexidine  

Official title:

The Minimum ChloraPrep Drying Time Before Neuraxial Anesthesia in Elective Cesarean Delivery Patients - Prospective Observational Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02095535
• Other study ID #: H14-00623
• Status: Completed
• Phase: N/A
• First received: March 19, 2014
• Last updated: September 26, 2014
• Start date: April 2014
• Est. completion date: June 2014

Study information

• Verified date: September 2014
• Source: University of British Columbia
• Contact: n/a
• Is FDA regulated: No
• Health authority: Canada: Health Canada
• Study type: Observational

Clinical Trial Summary

Before a patient gets a spinal/epidural, their lower back is cleaned with an antiseptic solution diluted in alcohol called ChloraPrep. ChloraPrep must completely dry before starting the anesthetic procedure. It is not known how much time is needed for the solution to completely dry. The investigators aim to determine this.

As the ChloraPrep dries, the alcohol is converted into vapour. The investigators will be using a PPBRae 3000 device to detect small amounts of vapours in the air. As the ChloraPrep dries it gives off less and less vapour. The investigators will use this diminishing vapour concentration to determine when drying is complete.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. completion date: June 2014
• Est. primary completion date: June 2014
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 19 Years to 40 Years

Eligibility

Inclusion Criteria:

• Pregnant

• At full term

• Due to have a cesarean section under spinal or epidural anesthesia

• 19 to 40 years of age

Exclusion Criteria:

• Allergy to certain antiseptic solutions

• Not suitable for a spinal/epidural anesthetic

• Have a significant amount of hair on lower back

Study Design

Observational Model: Case-Only, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Drying Time

Intervention

Drug:
• Chlorhexidine gluconate
antiseptic

Locations

Country	Name	City	State
Canada	BC Women's Hospital	Vancouver	British Columbia

Sponsors (1)

Lead Sponsor	Collaborator
University of British Columbia

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Length of drying time	Length of drying time from when Chloraprep solution is applied to skin to when skin is deemed dry.	At Chloraprep application	Yes